Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1966 8
1967 12
1968 12
1969 16
1970 10
1971 5
1972 14
1973 18
1974 17
1975 14
1976 11
1977 6
1978 13
1979 8
1980 13
1981 4
1982 10
1983 7
1984 11
1985 14
1986 5
1987 13
1988 11
1989 10
1990 12
1991 10
1992 14
1993 13
1994 14
1995 12
1996 14
1997 11
1998 24
1999 21
2000 18
2001 22
2002 27
2003 25
2004 33
2005 28
2006 28
2007 37
2008 50
2009 29
2010 35
2011 43
2012 33
2013 44
2014 54
2015 45
2016 63
2017 58
2018 48
2019 49
2020 47
2021 57
2022 47
2023 40
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

1,260 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and treatment of idiopathic intracranial hypertension.
Raoof N, Hoffmann J. Raoof N, et al. Cephalalgia. 2021 Apr;41(4):472-478. doi: 10.1177/0333102421997093. Epub 2021 Feb 25. Cephalalgia. 2021. PMID: 33631966 Free PMC article. Review.
OBJECTIVE: To review and discuss the clinical presentation and treatment of idiopathic intracranial hypertension. ...Several hypotheses have been postulated but none of them can explain the full clinical picture. Therapeutic options remain limited, focusing mainly o …
OBJECTIVE: To review and discuss the clinical presentation and treatment of idiopathic intracranial hypertension. ...Several hypothes …
Update on Idiopathic Intracranial Hypertension.
Wall M. Wall M. Neurol Clin. 2017 Feb;35(1):45-57. doi: 10.1016/j.ncl.2016.08.004. Neurol Clin. 2017. PMID: 27886895 Free PMC article. Review.
The typical patient symptom profile is the presence of daily headache, pulse synchronous tinnitus, transient visual obscurations, and papilledema with its associated visual loss. Although surgical procedures are performed for those who fail medical therapy, their relative …
The typical patient symptom profile is the presence of daily headache, pulse synchronous tinnitus, transient visual obscurations, and pap …
The Diagnosis and Treatment of Optic Neuritis.
Wilhelm H, Schabet M. Wilhelm H, et al. Dtsch Arztebl Int. 2015 Sep 11;112(37):616-25; quiz 626. doi: 10.3238/arztebl.2015.0616. Dtsch Arztebl Int. 2015. PMID: 26396053 Free PMC article. Review.
METHODS: This review is based on articles retrieved by a selective search of the PubMed database, on the pertinent guidelines, and on the authors' clinical experience. RESULTS: The diagnosis of optic neuritis is based on a constellation of symptoms and signs. ...
METHODS: This review is based on articles retrieved by a selective search of the PubMed database, on the pertinent guidelines, and on the au …
Outcomes measures in idiopathic intracranial hypertension.
Mollan SP, Sinclair AJ. Mollan SP, et al. Expert Rev Neurother. 2021 Jun;21(6):687-700. doi: 10.1080/14737175.2021.1931127. Epub 2021 Jun 7. Expert Rev Neurother. 2021. PMID: 34047224 Review.
Introduction: Idiopathic intracranial hypertension is a condition characterized by raised intracranial pressure, papilledema, and normal neuroimaging (aside from radiological signs of raised intracranial pressure). Symptoms of idiopathic intracranial hypertension include c …
Introduction: Idiopathic intracranial hypertension is a condition characterized by raised intracranial pressure, papilledema, and nor …
Idiopathic intracranial hypertension: expanding our understanding.
Markey K, Hutchcroft C, Emsley H. Markey K, et al. Curr Opin Neurol. 2023 Dec 1;36(6):622-630. doi: 10.1097/WCO.0000000000001209. Epub 2023 Sep 28. Curr Opin Neurol. 2023. PMID: 37865852 Review.
Weight loss remains the most effective management strategy, but innovative treatments and randomized control trials (RCTs) remain few. This paper will review recent IIH research. ...Weight loss of 24% results in normalization of intracranial pressure (ICP) and improvement …
Weight loss remains the most effective management strategy, but innovative treatments and randomized control trials (RCTs) remain few …
Idiopathic intracranial hypertension.
Wall M. Wall M. Neurol Clin. 2010 Aug;28(3):593-617. doi: 10.1016/j.ncl.2010.03.003. Neurol Clin. 2010. PMID: 20637991 Free PMC article.
Although there are no evidence-based data to guide therapy, there is an ongoing randomized double-blind controlled treatment trial of IIH investigating diet and medical therapy....
Although there are no evidence-based data to guide therapy, there is an ongoing randomized double-blind controlled treatment trial …
Association between trastuzumab and papilledema.
Pérez-García P, Gómez-Calleja V, Ly-Yang F, Santos-Bueso E. Pérez-García P, et al. J Fr Ophtalmol. 2021 Apr;44(4):589-591. doi: 10.1016/j.jfo.2020.06.018. Epub 2021 Jan 6. J Fr Ophtalmol. 2021. PMID: 33419593 No abstract available.
Lithium-induced headache.
Alvarez-Cermeño JC, Fernández JM, O'Neill A, Moral L, Saiz-Ruiz J. Alvarez-Cermeño JC, et al. Headache. 1989 Apr;29(4):246-7. doi: 10.1111/j.1526-4610.1989.hed22904246.x. Headache. 1989. PMID: 2497083
A 23-year old woman developed headache and papilledema due to benign intracranial hypertension (BIH) while taking lithium carbonate for only seven months because of manic-depressive disease. ...
A 23-year old woman developed headache and papilledema due to benign intracranial hypertension (BIH) while taking lithium carbonate f …
Visual disturbances during prolonged space missions.
Khossravi EA, Hargens AR. Khossravi EA, et al. Curr Opin Ophthalmol. 2021 Jan;32(1):69-73. doi: 10.1097/ICU.0000000000000724. Curr Opin Ophthalmol. 2021. PMID: 33196542 Review.
A high-pressure situation.
Miller MJ, Hicks MJ, Foroozan R, Brodsky MC. Miller MJ, et al. Surv Ophthalmol. 2023 Jul-Aug;68(4):815-820. doi: 10.1016/j.survophthal.2022.08.001. Epub 2022 Aug 12. Surv Ophthalmol. 2023. PMID: 35970231
1,260 results